Skip to main content
PMC home page
Scientific Reports logoLink to Scientific Reports
. 2020 Jul 21;10:12057. doi: 10.1038/s41598-020-68970-8

The HERC1 ubiquitin ligase regulates presynaptic membrane dynamics of central synapses

Mª Angeles Montes-Fernández 1,#, Eva Mª Pérez-Villegas 2,#, Francesc R Garcia-Gonzalo 3, Leonardo Pedrazza 3, Jose Luis Rosa 3, Guillermo Alvarez de Toledo 1,✉, José A Armengol 2,✉
PMCID: PMC7374096  PMID: 32694577

Abstract

HERC1 is a ubiquitin ligase protein, which, when mutated, induces several malformations and intellectual disability in humans. The animal model of HERC1 mutation is the mouse tambaleante characterized by: (1) overproduction of the protein; (2) cerebellar Purkinje cells death by autophagy; (3) dysregulation of autophagy in spinal cord motor neurons, and CA3 and neocortical pyramidal neurons; (4) impairment of associative learning, linked to altered spinogenesis and absence of LTP in the lateral amygdala; and, (5) motor impairment due to delayed action potential transmission, decrease synaptic transmission efficiency and altered myelination in the peripheral nervous system. To investigate the putative role of HERC1 in the presynaptic dynamics we have performed a series of experiments in cultured tambaleante hippocampal neurons by using transmission electron microscopy, FM1-43 destaining and immunocytochemistry. Our results show: (1) a decrease in the number of synaptic vesicles; (2) reduced active zones; (3) less clathrin immunoreactivity and less presynaptic endings over the hippocampal main dendritic trees; which contrast with (4) a greater number of endosomes and autophagosomes in the presynaptic endings of the tambaleante neurons relative to control ones. Altogether these results show an important role of HERC1 in the regulation of presynaptic membrane dynamics.

Subject terms: Neurotransmitters, Synaptic vesicle endocytosis

Introduction

HERC1 is a giant phylogenetically conserved ubiquitin ligase of the HECT family1 that participates in the ubiquitin–proteasome system (UPS)2–3. Like other UPS alterations, mutations in HECT E3 ligases have been associated with the pathogenesis of neuromuscular disorders, Parkinson’s disease and diseases of the autism spectrum1–4. Furthermore, mutations in the RCC1 domain of human HERC1 have been related with X-linked retinitis pigmentosa and juvenile amyotrophic lateral sclerosis 25. In humans, missense mutations of Herc1 display polymorphic syndromes with or without cerebellar affectation6–8, in which the intellectual disability appears as the common neurological disorder8.

The tambaleante (tbl) mutant mouse was earliest reported as a model of adult cerebellar ataxia caused by the almost complete autophagy cell death of cerebellar Purkinje cells9–11. In addition to adult cerebellar Purkinje cell degeneration5,9–12, other alterations in the central and the peripheral nervous system have been recently described in tbl mouse such as: (1) increase of autophagy signs in spinal cord motor neurons and neocortical and CA3 hippocampal pyramidal neurons13; (2) impairment of the associative learning associated to absence of long term potentiation (LTP), altered dendritic spinogenesis, and a drastic decrease of glutamatergic innervation of the lateral amygdala14; (3) anomalous myelination in the sciatic nerve together with alterations of non-myelinating terminal Schwann cells at the neuromuscular junction (NMJ)15; and, (4) altered motor performance owing to a reduction of the motor end-plate area, and impaired evoked neurotransmitter release at the NMJ16. Molecular studies identified that HERC1 mutation carried by the tbl mice, and responsible for autophagy cell death, is a Gly483Glu spontaneous substitution located in the N-terminal RCC1 domain (RLD1)5. This domain acts as guanine nucleotide-release factor for ARF proteins and influences intracellular vesicle trafficking interacting with ARF/Rab GTPases1–2. Furthermore, C-terminal RCC1 domain (RLD2) of HERC1 forms a ternary complex with clathrin (CLT) and the heat shock protein 70, and might influence intracellular vesicular trafficking17.

These data together strongly suggest that HERC1 mutation of tbl mouse might alter the normal dynamic of excitatory presynaptic terminals. Furthermore, CLT mediated endocytosis (CME) is a key step for synaptic vesicle recycling18; thus, alterations of HERC1-CLT interaction1,17 might alter the normal CLT cycle interfering with the normal synaptic function. Therefore, to elucidate the putative role of HERC1 in the synaptic vesicle populations of central excitatory synapses and in their presynaptic dynamics, we have analyzed tbl hippocampal neuronal cultures in vitro by using transmission electron microscopy, immunocytochemical, GFP pull-down and FM1-43 destaining methods.

Results

In present experiments those synapses of control (Fig. 1A) and tbl (Fig. 1B) hippocampal cultures showing a clear synaptic cleft, and evident thickening of pre- and postsynaptic zones were only considered for vesicle counts and active zone length measurement. The number of round and clear synaptic vesicles counted and the active zone length were significantly fewer (Fig. 1C) and shorter (Fig. 1D) in tbl synapses relative to control ones. However, significant differences were neither found in the mean diameter of the synaptic vesicles (Fig. 1E,∅) nor in the intervesicular distance (Fig. 1E) between control and tbl synapses. Furthermore, there was no statistically significant differences in the number of tethered synaptic vesicles (Fig. 1G); and, although the numbers of vesicles located in the nearest (< 75 nm) and farthest (225–300 nm) compartments of tbl synapses were fewer than in control ones, their values were not significant (p = 0.0853 and p = 0.2318 respectively) (Fig. 1H). However, a clear significant statistical difference in the number of docked vesicles was found, whose number was ever higher in control synapses relative to in tbl ones –as much in absolute values (Fig. 1F, AZ) as in normalized values relative the mean value of tbl active zone values (Fig. 1F, 500 nm AZ).

Figure 1.

Figure 1

Open in a new tab

Electron microscopy microphotographs illustrating the ImageJ counts of the number of synaptic vesicles in control (A) and tbl (B) hippocampal cultures. The active zone is consistently shorter in tbl than in control presynaptic boutons (D; *p = 0.0246). Quantitative analyses demonstrate that tbl synapses possess less synaptic vesicles than control ones (C; *p = 0.0391), and fewer docked synaptic vesicles in both absolute (F AZ, *p = 0.0470) and normalized values (F; 500 nm AZ, *p = 0.0265). However, no significant statistic differences are found in the synaptic vesicles diameter (E; ∅, p = 0.1452), the intervesicular distance (E, iV distance, p = 0.2184), in the number of tethered vesicles (G; AZ, p = 0.2011; 500 nm AZ, p = 0.0834), and in the number of vesicles respecting their distance from the active zone (H; < 75 nm, p = 0.0853; 75–150 nm, p = 0.4834; 150–225 nm, p = 0.4342; 225–300 nm, p = 0.2318). Bars = 200 nm.

To quantify synaptic vesicles pools we use the fluorescence lipophilic dye FM1-43, that label synaptic boutons in an activity-dependent manner that involves dye uptake by synaptic vesicles that are recycling19. Hippocampal cultures of control and tbl mutants were loaded with FM1-43 dye after the application of 600 pulses (Fig. 2A and D). The amount of FM1-43 loaded depends on the recycling activity of the neuron. Control cultured neurons revealed a greater amount of fluorescence as compared to tbl ones (450 ± 40; n = 6, vs 250 ± 35; n = 5) indicating larger dye loading. Unloading of FM1-43 of individual boutons for control and tbl revealed a large variability in both animals, reflecting a diversity of individual boutons in the amount of dye loaded (Fig. 2B and E). A set of 40 and 700 pulses were sufficient to unload dye completely in both control and tbl cultured neurons (Fig. 2C and F). A comparison of the destaining of FM1-43 for the control and tbl is shown in Fig. 2G. Quantification of the fluorescence change upon different levels of stimulation is shown in Fig. 2H. The application of 40 pulses produced a decrease of 45.7 ± 20.4 fluorescence units in the control (n = 4) versus 16.1 ± 8.9 in the tbl mutant (n = 4). This fluorescence change corresponds to approximately 9 vesicles in the RRP for the control and 3 for the tbl mutant, since previous experiments in the same set up revealed 5 fluorescence units per synaptic vesicle20. The application of 700 consecutive pulses, sufficient to deplete the reserve pool, showed also a significant difference between the control and the tbl mutant hippocampal cultured neurons (238.9 ± 108 vs. 122 ± 51.3; n = 100 and n = 75 boutons, p = 0.007).

Figure 2.

Figure 2

Open in a new tab

FM1-43 destaining of control and tbl hippocampal neurons in culture with successive applications of 40 APs, to deplete the RRP, and 100 plus 600 APs to deplete the reserve pool of synaptic vesicles. (A), control neuron stained with FM1-43. The ROIs are shown in red. (B), time course of FM1-43 destaining for multiple boutons. (C), Average FM1-43 destaining (left axis normalized fluorescence, right axis total fluorescence. (D), tbl hippocampal neuron stained with FM1-43. ROIs marked in red as in (A). (E,F), time course of FM1-43 destaining for tbl hippocampal neurons for individual boutons (E) and the average response (F). (G), superposition of control and tbl FM1-43 response for comparison. Note that control neurons were better loaded than tbl mutant neurons. (H), both, the RRP and the size of the reserve pool of synaptic vesicles were smaller in the tbl mutant, suggesting a lower size of dock and recycle vesicles. The asterisks indicate significant differences in the Student’s t test: ***p = 0.04).

Cultured tbl hip21pocampal neurons seem not show evident qualitative differences in size relative to control ones. The use of microtubule associated protein 2 (MAP2) as neuronal dendritic marker allowed us to analyze the neuronal expression of CLT (Fig. 3A-B). Control hippocampal neurons expressed strongly both markers relative to tbl ones; and the quantitative analyses demonstrated the existence of significant differences in the absolute (Fig. 3C and E) and normalized values relative to the analyzed area (Fig. 3D and F) of MAP2 and CLT expression. As CLT plays a key role in the synaptic vesicle endocytic recycling22, we have analyzed the immunocytochemical expression of CLT together to the presynaptic SV2B protein as general marker of synaptic vesicles (Fig. 4A-B). The expression of both markers was significantly higher in control cultured neurons than in tbl ones (Fig. 4C-F). Moreover, the counts of presynaptic boutons expressing SV2B alone or co-expressing with CLT (Fig. 5A-B) clearly indicated that the number of presynaptic boutons lying over the main dendrites of control hippocampal neurons analyzed here was higher than those ending on the main dendrites of tbl hippocampal neurons (Fig. 5C, T); this significant difference in the number of synaptic boutons is consistent from both SV2B single (Fig. 5C, SV2B) and double labelled boutons (Fig. 5C). When these numbers were normalized regarding their density relative to each µm of dendritic shaft measured, difference clearly ratifies that the density of synaptic boutons ending on the main dendrite of tbl hippocampal neurons was the half in relation to the control (Fig. 5E). The reduction in the density of presynaptic boutons is also correlated with a significant decrease in the immunolabelling of synaptotagmin 1 (SYT1), a presynaptic ubiquitous protein22, in tbl cultured neurons in relation to control cultured neurons (Fig. 6D).

Figure 3.

Figure 3

Open in a new tab

Laser confocal microphotographs of hippocampal cultures from control (A), and tbl (B) mice illustrative of MPA2 (green) and CLT (red) immunocytochemistry. (C–F), graphical representation of the fluorescence intensities of MAP2 and CLT in absolute values per image (C,E); and relative to the % of measured area (D,F). In both absolute (C,E) and relative (D,F), values, MAP2 and CLT expressions are higher in control cultures than in tbl ones. The asterisks indicate significant differences in the Student’s t test: ***p = 0.0008 (C); **p = 0.005 (D); ***p = 0.0005 (E); and ***p = 4.4E−06 (F). Bars = 50 µm. a.u., arbitrary units.

Figure 4.

Figure 4

Open in a new tab

Laser confocal microphotographs illustrative of SV2B (green) and CLT (red) immunoreactivities in control (A) and tbl (B) hippocampal cultures. (C–F), graphs showing the fluorescence intensities of CLT (C, D) and of synaptic vesicles identified by SV2A immunoreactivity (E,F). In both absolute and % relative values, fluorescence intensity was higher in control than in tbl cultures (C, **p = 0.004; D, **p = 0.002; E, **p = 0.004; F, **p = 0.003). Bars = 30 µm. a.u., arbitrary units.

Figure 5.

Figure 5

Open in a new tab

ImageJ composites illustrative of the count of presynaptic boutons expressing SV2B (green), CLT (red), or both immunoreactivities in control (A) and tbl (B) hippocampal cultures. (C–E), graphs showing the number of single SV2B and double (SV2B-CLT) labelled boutons (C), the percentage of labelled boutons (D), and their density of counted boutons per dendrite µm (E). The number of presynaptic boutons is higher in control relative to tbl cultures (C, T: *p = 0.014; SV2B-CLT: **p = 0.005; SV2: *p = 0.04). Correlative to these counts, the percentage of double labelled boutons is lower in tbl cultures relative to control ones (D, SV2B-CLT: **p = 0.007). The density of the number of all categories of presynaptic boutons counted is ever lower in tbl cultures than in control ones (E, T: **p = 0.005; SV2B-CLT: **p = 0.003; SV2: **p = 0.009), while no significant differences were found on the mean of the dendrite’s length measured (F; p = 0.544). Bars = 5 µm. T, total number of counted boutons.

Figure 6.

Figure 6

Open in a new tab

Laser confocal microphotographs illustrative of HERC1 (red) and SYT (green) immunoreactivities in control (A) and tbl (B) hippocampal cultures. HERC1 is expressed in both the neuronal nucleus (A–B, n) and cytoplasm (A–B, arrows). (C–D) graphs showing the fluorescence intensities of HERC1 (C) and of presynaptic terminal endings identified by SYT (D). Herc1 expression is greater in tbl cultured neurons relative to control ones (C, *p = 0.04723). In contrast, SYT immunoreactivity is considerably higher in control cultured neurons compared to tbl ones (D, *p = 0.04651). Bars = 5 µm.

In our hands the commercial antibody used here against the HERC1 in hippocampal cultures (Figs. 6 and 7) shows that the expression of this protein is distributed through the cell nucleus and the cytoplasm (Figs. 6A-B and 7A-B). In all analyzed cultures, HERC1 expression was significantly more intense in tbl hippocampal neurons than in controls (Figs. 6C and 7C).

Figure 7.

Figure 7

Open in a new tab

ImageJ composites illustrative of the expression of HERC1 (red) and EEA1 (green), in control (A) and tbl (B) hippocampal cultures. (C–E), graphs show the intensity of the expression of HERC1 (C) and EEA1 (D). HERC1immunoreactivity is higher in tbl relative to control cultures (C, *p = 0.0404). Likewise, EEA1 expression is lower in control cultures relative to tbl ones (D, *p = 0.04276). Bars = 5 µm. n, neuronal cell nucleus.

Apart the differences in the number of rounded vesicles, an also clear qualitative difference on the size of the endosomes was observed between tbl and control presynaptic endings (Fig. 8A to D). From seminal works of Heuser and Reese23 the endosomes located in the presynaptic endings have been related with the synaptic vesicles recycling. In present observations, quantitative analysis of the main components of the CLT recycling pathway24–25 demonstrated statistic significant differences on the number of CLT coated vesicles, endocytic pits, and endosomes. Thus, while control presynaptic terminals contained more coated vesicles, and endocytic pits than tbl ones (Fig. 8E); the number of endosomes was greater in tbl presynaptic boutons relative to control ones (Fig. 8E). Moreover, the qualitative appearance that tbl endosomes were bigger than control ones is clearly ratified by the measurement of their maximum diameters that were twice in tbl presynaptic endings relative to the control ones (Fig. 8F). This dysregulation of the recycling endocytosis pathway is reinforced by present immunocytochemical experiments. Early endosome antigen 1 (EEA1) distributed through the neuronal cytoplasm (Fig. 7A-B); and the quantitative analysis shows significant differences of the immunocytochemical expression of EEA1 between tbl and control cultured hippocampal neurons, being almost twice in tbl neurons regarding the control ones (Fig. 7D).

Figure 8.

Figure 8

Open in a new tab

Electron microphotographs illustrating the main differences between control (A,C) and tbl (B,D) coated vesicles (cv) and endosomes (e). Coated vesicles and endocytic pits are most numerous in control than in tbl synaptic boutons (E, ***p = 2.559E−08; **p = 0.00936, respectively). Otherwise, endosomes were most numerous (E, **p = 0.00543) and greater (F, ***p = 0.00016) in tbl than in control presynaptic endings. The arrow in A indicates a coated vesicle integrating into an endosome. Bars = 200 nm.

Another important finding of present experiments is related with the presence of autophagy vacuoles. Thus, from earliest reports, the ultrastructural features of these vacuoles as it is the presence of double membrane encircling damaged or ubiquitinated proteins26 help their easy identification. Autophagosomes and mitochondrial debris (Fig. 9B) are often observed in tbl presynaptic boutons; and, in addition to the previously described differences in the endosomes’ number and diameters between control cultured hippocampal neurons and tbl ones; the values of the counts of these vesicles showed an important increment of their number within tbl presynaptic terminals (n = 26) relative to control ones (n = 30) (Fig. 9C). From these observations it seems that the membrane dynamics of the presynaptic terminal might be altered in the tbl mutation. As the synaptic transmission takes place at the terminal active zone, which is smaller in tbl presynaptic terminal than in control ones (Fig. 1C-D), we have measured the perimeter of the presynaptic boutons, the perimeter of the endosomes and the perimeter of the autophagosomes and compared these in absolute values and as their ratios in relation to the active zone length (Fig. 9). Thus, while the values of presynaptic boutons perimeters and of the sum of the perimeter of the plasma membrane surrounding the bouton and that of the endo- and autophagosomes did not shown significant differences between control and tbl terminals (Fig. 9D), the perimeter of endosomes and autophagosomes was significantly greater in tbl terminals than in control ones (Fig. 9D). When the size of active zone is analyzed according their ratio respective to the values of the perimeter of the rest of presynaptic ending membranes were measured, there were significant differences between control and tbl presynaptic terminals in which these ratios were ever highest in control presynaptic boutons (Fig. 9E).

Figure 9.

Figure 9

Open in a new tab

Electron microphotographs of tbl synapses (A–B) in which great endosomes (E) and autophagy vacuoles (a) are easily distinguished. Autophagosomes are most numerous in tbl than in control presynaptic terminals (C, ***p = 8.09153E−05). No differences stand out in the perimeter length of the presynaptic boutons (D, Perimeter; p = 0.06094) as well as in the perimeter of all membranes measured (D, Total; p = 0.22775) between control and tbl presynaptic boutons; however, the perimeter of the membrane of endosomes and autophagosomes (D, Endosomes) is significantly greater in tbl than in control presynaptic terminals (***p = 5.7819E−07). The ratios between the active zone and the perimeter length (E, AZ/Perimeter), the values of endodomes and autophagosomes membrane length (E, AZ/Endosomes), and the total length of measured membranes (E, AZ/Total) are consistently greater in control presynaptic terminals than in tbl ones (***p = 2,769E−06; **p = 0.0017; and, ***p = 1.8152E−09, respectively). cv, coated vesicles. dcv, dense core vesicles. e, endosomes. m, microtubules; mvb, multivesicular body. sr, smooth endoplasmic reticulum. Bars = 500 nm.

Although previous experiments described that HERC1-CLT interaction takes place through RLD2 domain17, we have tried to analyze the possible role that mutated RLD1 domain could play in this interaction. However, the fusion of proteins with amino acid residues of HERC1 RLD1 domain in cultured control and tbl hippocampal neurons experiments was not yet attained accurate levels in our hands. Therefore, as indirect analysis we have transfected HEK-293 T cells transfected with pFG41 (RLD1 control), pFG44 (RLD1 tbl) or GFP fusion constructs. 72-h post-transfection, the immunoblot of protein retained in the resin of the cell lysates demonstrated that in contrast to pFG41, pFG44 did not interact with CLT (Fig. 10, and Supplementary Information). Thus, this result shows for the first time that tbl RLD1 domain alters HERC1-CLT interaction, and open the possibility that this lack of interaction might be also present in tbl central synapses.

Figure 10.

Figure 10

Open in a new tab

Impairment of the interaction between the RLD1 domain and the clathrin heavy chain (CLThc) by the tambaleante (tbl) mutation. GFP fusion proteins with the amino acid residues of HERC1 RLD1 domain are shown. The pFG44 construct (RLD1 tbl) has a point mutation, resulting in a Gly → Glu substitution at 483 amino acid residue of HERC1. Pull-down experiments were performed in HEK-293 T cells transfected with pFG41, pFG44 or GFP fusion constructs. After 72 h post-transfection, cell lysates were incubated with GFP-Trap Agarose resin for 2 h. Proteins retained in the resin were analyzed by immunoblotting using specific antibodies against the indicated proteins (see Supplementary information). Note the absence of interaction between HERC1 and pFG44 construct.

Discussion

Biallelic Herc1 mutation causes in humans a polymorphic syndrome with varied signs and symptoms6–8, together with intellectual disability [see table 1 in ref.8]. Recently a new Herc1 mutation characterized by the synthesis of a truncated Herc1 protein lacking the C-terminal of HECT domain has been described, in addition with signs of the autism spectrum27. The animal model of HERC 1 mutation, the tambaleante mouse, was first described as an example of adult cerebellar ataxia by autophagy Purkinje cell death5,9–12. Later studies showed more neurodevelopmental damages to tbl mice phenotype as: (1) delay in synaptic development and maturation of NMJ16; (2) anomalous myelination of peripheral nerves and delayed action potential transmission15; (3) increase of autophagy signs in projection neurons of central nervous system as the hippocampal CA3 pyramidal neurons, the neocortical pyramidal neurons, and the motor neurons of the spinal cord13; and, (4) impairment of associative learning linked to absence of LTP and anomalous spinogenesis of the neurons of the lateral amygdala14. Therefore, as part of the ubiquitin–proteasome system (UPS) whose alterations have been related with several neurodegenerative diseases of nervous system28–34, all these findings have been explained as the effect of the dysregulation of the autophagy5,13–15 and/or of the mammalian target of rapamycin complex 1 (mTORC1) altered regulation5,15. Present results in hippocampal cultured neurons show that tbl presynaptic terminals possess a noticeable decrease in the number of presynaptic terminals relative to the control ones, which in addition display: (1) a lower number of the ready releasable and the reserve pools of synaptic vesicles; (2) a shorter zone active; (3) less docked synaptic vesicles; (4) less SYT1; (5) less CLT coated vesicles and CLT immunoreactivity; (6) increased number of big endosomes correlated with and also high expression of EEA1; and, (7) an important presence of autophagosomes. These results are in accordance with previous findings in tbl mice in vivo. The decrease in the number of clear and round synaptic vesicles, in SYT1 expression as in the SV2B expression in tbl cultured neurons correlates with the decrease of SV2B-VGLUT1 co-expressing vesicles found in the lateral amygdala of adult tbl mice14. Furthermore, a diminution of the ready releasable pool of synaptic vesicles (RRP) together with a decrease in the probability of release was also found at the tbl NMJ16. Hence, all these data together strongly suggest that HERC1 might play a pivotal role in the presynaptic activity and the synaptic vesicle dynamics.

Postmitotic neurons are highly specialized cells whose presynaptic terminals lye several dozens or hundreds of microns far from the cell soma, and therefore part of the protein turnover resulting from the high synaptic activity takes place locally. Thus, more and more experimental evidences demonstrate that autophagy homeostasis, as well as their dysregulation eliciting neurodegenerative diseases, takes place at the presynaptic terminals35–38. In fact, studies in another model of ataxia involving Purkinje cell degeneration, the Lurcher mutant mouse, demonstrated that Purkinje cell axons react earlier and more strongly to autophagy than the Purkinje cell bodies39. Furthermore, Lurcher mice lacking the Atg7 gene that encodes the autophagy-related protein 7 showed that axonal degeneration occurs prior to and independently of Purkinje cell death40. Indeed, it is now well established that axon terminals accumulate the greatest number of neuronal autophagosomes41 and that autophagy is key to preventing axonal degeneration after injury42.

The synaptic vesicle recycling pathways are far to be completely understood43–45. The endosomes play a pivotal role at least in two of these pathways: the CLT mediated endocytosis (CME), and the ultrafast endocytosis (UFE)23,44 provide: (1) the renewal of synaptic vesicles (CME and UFE); and/or (2) the elimination of damaged components of synaptic vesicles by lysosomal degradation (CME)46. Our results demonstrate an increase in the number of endosomes within the tbl presynaptic endings, which correlates to an also higher expression of EEA1 and with the presence of multivesicular bodies (Fig. 9). The clear deficit of CLT together to the reduction in synaptic vesicles number in tbl presynaptic endings could imply that less fused synaptic vesicles could integrate within the early endosomes, and could alter the complex process of endosomes maturation. In fact, alterations in the endosomes size and maturation have been reported in several neurological and neurodegenerative diseases [for a rev see46]. Therefore, our present findings open an interesting work line to analyze what of the proteins (CME interactors47, GTP-Rab interactions, i.e., see below) involved in the complex process of endosome maturation are altered by the HERC1 mutation. In fact, the role of CLT in the maintenance of synaptic vesicles number and in the endosomes homeostasis suggested by our observations, have been elegantly demonstrated by Kononenko et al.48, whose experiments with CLT KO mice, clearly demonstrated the depletion in synaptic vesicles together to endosome accumulation; two morphological data which are similar to that present the tbl presynaptic endings.

Several pathways might be dysregulated in the tbl mutation to control autophagy, proteostasis and the synaptic vesicle cycle35–38. These includes: (1) GTPases Rab family; (2) CLT; and (3) mTOR.

Amongst their many several functions, the GTPases Rab family has been involved in synaptic vesicles autophagy through the canonical endosomal-lysosomal system36,49. Moreover, the work of Binotti et al.50 demonstrated that Rab26 might be responsible for an independent pathway or vesiculophagy in which synaptic vesicles unable to recycle are redirected to the autophagosome in a non-canonical form. HERC1 RLD1 acts as a small GTPase regulator and inhibits GTPases Rab family1,51. Therefore, it could be conceivable that mutated RLD1 domain might alters the regulatory action of HERC1 on the GTPases Rab family affecting the mechanism of synaptic vesicles recycling (Fig. 11A).

Figure 11.

Figure 11

Open in a new tab

Schematic representation of the four pathways that the tbl mutation might dysregulate allowing to an increase of the autophagy of synaptic vesicles and the alteration on the number of healthy releasable synaptic vesicles. (A) Mutation site is located at RLD1 domain which dysregulating small GTPS might in turn dysregulate synaptic vesicles homeostasis. (B) RLD2 domain binds clathrin; therefore, alterations of RLD2 alone or by protein overproduction could alter endocytosis during synaptic vesicle recycling. (C) CLT-HERC1 interaction is impaired by mutated RLD1 and in turn could interfere the CME pathway. (D) mTORC1 activity decreased in tbl mutation and could thus explain the increase of autophagosomes; otherwise, mTORC1 participates in autophagy of presynaptic proteins whose dysregulation might contribute to the decrease in size of the active zone (AZ).

CME is a key pathway for synaptic vesicles recycling at the presynaptic terminal18,24,25. CLT coated vesicles are uncoated by the action of the complex Endophilin A (Endo A)-Synaptojanin 1 (Synj 1)25,51. Synj 1 has been recently described as an autophagy regulator promoting the autophagosomes maturation36,51,52. Furthermore, a link between CLT coated vesicles and the autophagosome precursors has been described in basis to CLT-Atg 16 L1 (Autophagy related 16 like 1 protein) interaction53,54. HERC1 RLD2 interact with CLT and cytoplasmic vesicle trafficking1,17, and tbl mutation might alters CLT balance (Fig. 11B), as demonstrated by the decrease of CLT immunoreactivity and coated vesicles found in cultured hippocampal tbl neurons. These, correlate with the decrease in the number of synaptic vesicles and the increase in number and size of the endosomes in these neurons, indicative of a dysregulation of the synaptic vesicles recycling via CME. Whether the relationships between autophagy factors such Synj 1 or Atg 16 L1 should be further investigated to exclude that results found here are exclusively promoted by the CLT downregulation. Further, our GFP pull-down experiments in transfected HEK-293 T cells demonstrated that mutated HERC1 RLD1 domain was unable to interact with CLT (Fig. 11C), indicative that HERC1 mutation directly alters normal CLT dynamic55, irrespective of the role that such interaction will play through RLD2 domain, being suggestive that this disbalance could be also elicited in tbl central synapses.

The mTORC1 plays a key role in autophagy56, and its inhibition enhances autophagy, inducing a loss of dopaminergic synaptic vesicles57. In normal conditions, HERC1 could regulate mTORC1 activity through interaction with the tuberous sclerosis complex 2 (TSC2)58, helping thus to maintain the homeostatic autophagy; however, the activity of mTORC1 is reduced by HERC1 overproduction in the tbl mutation5, and this decrease in mTORC1 action could dysregulate autophagy and neuronal cell death found in tbl mice5. Therefore, the increase of autophagosomes and multivesicular bodies, and at least in part the decrease in the number of synaptic vesicles could be explained by a misfunction of the HERC1 protein in tbl mutation (Fig. 11D).

In conclusion, although the specific targets and pathways damaged by the HERC1 mutation are still unsolved, our results ratify and extend previous in vivo findings and leads us to hypothesize that HERC1 mutation alters central synapses dynamic by impairing the normal CLT balance, altering thus the homeostasis of synaptic vesicles recycling. Therefore, we postulate HERC1 as an important regulator in neurodevelopment, and particularly in the alterations of synaptic transmission homeostasis, one of the bases of the intellectual disability.

Materials and methods

Animals

Tambaleante mice were obtained by breeding pairs of the tbl carrier mice, genotyping the offspring by PCR5 at birth (P0). The animals were handled in accordance with current Spanish and European legislation governing the use of experimental animals (RD 53/2013—BOE 08/02/2013 and 2010/63/EU), and all experimental procedures were approved by the University of Seville and Pablo de Olavide University ethics committees, and the Junta de Andalucía (Animal Health Service auth. # 13/06/2017/080).

Cell culture

Hippocampal neurons from control and tbl P0-P1 mice were cultured as described previously20. Every set of experiments were performed in littermates. CA1 and CA3 hippocampal regions from both sides were isolated and removed from the brain of P0–P1 newborn mice. The two hippocampi were immersed in 1 ml of enzymatic solution and kept under continuous agitation (80 rpm) for 40 min and centrifuged at 200×g for 5 min. The enzymatic solution was previously bubbled with 95% O2 and 5% CO2 for 20 min, and contained 1 ml of DMEM (PAA Laboratories), 0.2 mg of cysteine, 1 mM CaCl2, 0.5 mM EDTA and 5 units/ml papain (Worthington). After centrifugation, the supernatant was removed, and 1 ml of inactivating solution [800 μl of DMEM (Gibco), 200 μl FBS (BioWest), 200 units of penicillin (Gibco), 200 μg of streptomycin (Gibco), 2.5 mg albumin and 2.5 mg trypsin inhibitor (Sigma)] was added to the tissue to prevent further digestion. Thereafter, the tube was centrifuged again at 200 × g for 5 min and mechanically dispersed afterward with a 1 ml pipette tip five times. The supernatant was discarded and replaced with neuronal media, containing: 1 ml Neurobasal (Gibco), 20 μl B27 (Gibco) (50 ×), 10 μl Glutamax (Gibco) (100 ×), 20 units penicillin and 20 μg streptomycin. Neurons were plated at a density of 150,000 cells/well (12-well plates) over a single feeding layer of astrocytes grown on 15 mm ϕ coverslips20. Neurons were cultured between 14–17 DIV in an incubator at 37 °C with an atmosphere of 95% O2 and 5% CO2.

Transmission electron microscopy (TEM)

Coverslips containing hippocampal neuronal cultures were fixed with 2% paraformaldehyde, 2.5% glutaraldehyde and 0.02% CaCl2 in 0.1 M cacodylate buffer (pH 7.3) (CB) for 1 h at 4 °C. Thereafter the cultures were treated with 2% osmium tetroxide in CB, 1% uranyl acetate in 70% ethanol, dehydrated with an increasing gradient of ethanol and embedded in Durcupan (Fluka®). Ultrathin Sects. (50–70 nm thick) were cut with a Leica UC6 ultramicrotome, collected in copper grids (150 and 300 mesh) and one-slot formvar coated grids, and observed by TEM without counterstaining on a Zeiss Libra microscope at 80 kV (CITIUS, University of Seville).

For synaptic vesicles count w®e have followed the methodology proposed by Schikorski and Stevens59. Presynaptic endings (control n = 30; and tbl n = 26) were divided in four compartment (75 nm width each) parallels to the active zone. All counting was done with the Fiji ImageJ software (W. Rasband, National Institutes of Health, https://imagej-nih.gov/ij/). Parameters considered here were: (1) the total number of vesicles; (2) the active zone length; (3) the synaptic vesicles diameter; (4) the intervesicular distance; (5) the number of docked vesicles; (6) the number of tethered vesicles; (7) the number of synaptic vesicles for each 75 nm width compartments; (8) the number of CLT coated vesicles; (9) the number of endocytic pits; (10) the number of endosomes; and (11) the maximum diameter of the endosomes.

FM1-43 loading

On the day of the experiment the coverslips were brought from the incubator, and the media solution exchanged with the recording solution (in mM: 140 NaCl, 2.4 KCl, 10 HEPES, 4 CaCl2, 4 MgCl2, 10 glucose, pH 7.3, osmolality 305 mmol/kg). Neurons were used for up to 45 min without superfusion. All chemicals used were from Sigma-Aldrich, except the culture media products (GIBCO), and papain (Worthington).

Synaptic terminals were loaded by substitution of basal solution with 70 mM [K+] Locke solution (generated by equimolar replacement of NaCl by KCl) containing 4 μM FM1-43 (Molecular Probes) for 2 min. For imaging experiments, we use an inverted microscope IX-71 (Olympus) located on an isolation table. The recording chamber was set up on a separate XY stage attached to an optical bench column. A 3-axis mechanical manipulator was also attached for micropipette positioning. The microscope camera port allows 100% light reflection to which a QE-Sensicam camera (12 bit, PCO) was attached. The light source was a monochromator polychrome IV (100 W Xenon lamp) (Till Photonics). Image acquisition and illumination were controlled with TILL Vision software. Images were collected through a plan-NeoFluor 40 × objective (0.75 NA). Excitation of the FM1-43 was done at 488 nm and the emission light was collected through a band-pass emission filter (510 ± 10 nm). The pixel size was 0.32 μm. Neurons were stimulated by placing a micropipette near the soma (≈ 5–10 μm). Micropipettes were pulled in a P97 (Sutter Instruments) puller, having a resistance between 1–2 MΩ, when filled with the recording solution. Neuronal stimulation was done with an electrical stimulator (model 2,100, AM-Systems) by passing biphasic 1 ms pulses of 45–50 μA. A TTL signal generated with the TILL Vision software triggered stimulation and data acquisition. We collect 250 images per experiment. Exposure time was 800 ms, the image sampling rate was 1 frame/s. We used Igor Pro 6.22 (Wavemetrics Inc) custom made macros for image analysis. Synaptic responses were identified as regions the destaining of fluorescence. The ROIs were a square of 5 × 5 pixels (1.6 μm by 1.6 μm for a 40 × objective). For analysis, we use a Kolmogorov–Smirnov to check the normality of the samples and apply a t test to compare mean values.

Immunocytochemistry and quantification

Hippocampal cultures were fixed with 4% paraformaldehyde in 0.12 M phosphate buffer (pH 7.2–7.4). After fixation, the cultures were washed in PBS, and immunolabelled using the procedure reported previously13–14 The primary antibodies used were: a mouse monoclonal antibody against clathrin (CLT) light chain (1:500, Synaptic Systems, #113,011); a mouse monoclonal antibody against early endosome antigen 1 (EEA1) (1:50, ThermoFisher,MA-14794); a rabbit polyclonal antibody against HERC1 (1:150, ThermoFisher,PA5-62,033); a rabbit polyclonal antibody against microtubule associated protein 2 (MAP2) (1:500, Synaptic Systems, #188,003); a rabbit polyclonal antiserum against the presynaptic vesicle protein SV2B (1:200, Synaptic Systems, #119,102); and a mouse monoclonal antibody against synaptotagmin 1 (SYT1) (1:100, Synaptic Systems, # 105,011). The secondary antibodies used were: a donkey anti-rabbit IgG (H + L) highly cross-adsorbed antibody, Alexa Fluor 488 (1:500, ThermoFisher, #A-32790); a donkey anti-rabbit IgG (H + L) highly cross-adsorbed antibody, Alexa Fluor 555 (1:500, ThermoFisher, #A-31572); a donkey anti-mouse IgG (H + L) highly cross-adsorbed antibody, Alexa Fluor 555 (1:500, ThermoFisher, #A-31572); and a goat anti-mouse IgG (H + L) cross-adsorbed antibody, Alexa Fluor 488 (1:500, ThermoFisher, #A-11001).

The images were acquired on an upright Olympus FluoView 1,000 confocal laser scanning microscope. The figures were prepared using the Photoshop 7.0 (Adobe®) software without any additional correction.

Immunoreactivity was quantified as indicated previously14. Briefly, an alternating sequence of laser pulses was used to activate the different fluorescent probes during image acquisition. Images were acquired with a 60 × oil-immersion objective (N.A. 1.42). Images from the hippocampal cultures of control and tbl mice were obtained in the same session under similar conditions (laser intensities and photomultiplier voltages). Quantification of the fluorescent labelling intensity was performed offline with ImageJ and the size of the areas measured was determined automatically by defining outline masks based on the brightness thresholds from maximal projected confocal images. The control and tbl images of CLT, EEA1, HERC1, MAP2, SV2B and SYT were captured as follows and expressed in arbitrary units: (1) CLT: Rhodamine laser intensity 5% with photomultiplier settings HV 410, Gain 2, Offset 25; (2) EEA1: FITC laser intensity 4% with photomultiplier setting HV 530, Gain 3., Offset 15; (3) HERC1: Rhodamine laser intensity 1% with photomultiplier setting HV 600, Gain 3, Offset 13; (4) MAP2: FITC laser intensity 10% with photomultiplier setting HV 413, Gain 3, Offset 10; (5) SV2B: FITC laser intensity 5%, with photomultiplier settings HV 401, Gain 3, Offset 15; and (6) SYT1: FITC laser intensity 4% with photomultiplier setting HV 530, Gain 3., Offset 15.

Plasmids and pull-down experiments

pFG41 construct (GFP-RLD1 fusion containing 365–794 amino acid residues of HERC1) was previously described60. pFG44 construct was similar to pFG41 but containing the punctual mutation Gly483Glu found in tbl animals. This construct was generated from pFG41 using QuickChange XL Site-directed mutagenesis kit (Stratagene) following instructions of manufacturer. For the GFP pull-down, supernatants were incubated with 2μL of GFP-Trap© Agarose resin (Chromotek, Germany) around 2 h at 4 °C. After the incubation, the samples were centrifuged (2,500 g) and pull-downs were washed with NP40 buffer (three times). After each wash the samples were centrifuged again. Pellets were analyzed by electrophoresis and immunoblotting by using the following antibodies: anti-HERC1 (410)55, anti-GFP (Abcam), and anti-clathrin (CLT) heavy chain (hc) (BDBiosciences).

Statistical analysis

The statistical analyses of the data from the TEM, FM1-43 destaining, and immunolabelling experiments were analyed blind by EMP-V and MAM-F. A two tailed Student’s t test was used to compare the data from tbl and control hippocampal cultures. Any p-values less than 0.05 were considered significant, indicated as follows: * p < 0.05, ** p < 0.01, and *** p < 0.001.

Supplementary information

Supplementary information (6.6MB, pdf)

Acknowledgements

We are indebted to Dr L. Tabares for her generous help during the preparation of this work. We also thank Dr J.L. Ribas for his assistance at the CITIUS, and Dr I. de Benito for maintaining the animal facilities and the tambaleante mouse line. This work was supported by the following grants: GAT (Spanish Junta de Andalucía BIO-209 and MINECO-DGICYT BFU2015-64536-R); JAA (Spanish Junta de Andalucía BIO-122 and MINECO-DGICYT BFU2015-64536-R); and JLR (MINECO-AEI/FEDER, UE, BFU2016-80295-R).

Author contributions

Design: J.A.A. and G.A.de.T. Data acquisition, analysis and interpretation: M.A.M.-F., E.M.P.-V., F.G.-G., L.P., J.A.A., and G.A.de.T. Writing-original draft: J.A.A. and G.A.de.T. & J.L.R. Writing-review & editing: M.A.M.-F., E.M.P.-V., J.L.R., G.A.de.T., and J.A.A.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

These authors contributed equally: Mª Angeles Montes-Fernández and Eva Mª Pérez-Villegas.

Contributor Information

Guillermo Alvarez de Toledo, Email: gat@us.es.

José A. Armengol, Email: jaarmbut@upo.es

Supplementary information

is available for this paper at 10.1038/s41598-020-68970-8.

References

  • 1.García-Cano J, Martínez-Martínez A, Sala-Gaston J, Pedrazza L, Rosa JL. HERCing: Structural and functional relevance of the large HERC ubiquitin ligases. Front. Physiol. 2019;10:1014. doi: 10.3389/fphys.2019.01014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Sánchez-Tena S, Cubillos-Rojas M, Schneider T, Rosa JL. Functional and pathological relevance of HERC family proteins: A decade later. Cell. Mol. Life Sci. 2016;73:1955–1968. doi: 10.1007/s00018-016-2139-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Schneider T, et al. The E3 ubiquitin ligase HERC1 controls the ERK signaling pathway targeting C-RAF for degradation. Oncotarget. 2018;9:31531–31548. doi: 10.18632/oncotarget.25847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Sluimer J, Distel B. Regulating the human HECT E3 ligases. Cell. Mol. Life Sci. 2018;75:3121–3141. doi: 10.1007/s00018-018-2848-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Mashimo T, et al. Progressive Purkinje cell degeneration in tambaleante mutant mice is a consequence of a missense mutation in HERC1 E3 ubiquitin ligase. PLoS Genet. 2009;5:e1000784. doi: 10.1371/journal.pgen.1000784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Nguyen LS, et al. A nonsense Q4 variant in HERC1 is associated with intellectual disability, megalencephaly, thick corpus callosum and cerebellar atrophy. Eur. J. Hum. Genet. 2016;24:455–458. doi: 10.1038/ejhg.2015.140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Ortega-Recalde O, et al. Biallelic HERC1 mutations in a syndromic form of overgrowth and intellectual disability. Clin. Genet. 2015;88:e1–3. doi: 10.1111/cge.12634. [DOI] [PubMed] [Google Scholar]
  • 8.Aggarwal S, Bhowmik AD, Ramprasad V, Murugan S, Dalal A. A splice site mutation in HERC1 leads to syndromic intellectual disability with macrocephaly and facial dysmorphism: Further delineation of the phenotypic spectrum. Am. J. Med. Genet. A. 2016;170:1868–1873. doi: 10.1002/ajmg.a.37654. [DOI] [PubMed] [Google Scholar]
  • 9.Wassef M, Sotelo C, Cholley B, Brehier A, Thomasset M. Cerebellar mutations affecting the postnatal survival of Purkinje cells in the mouse disclose a longitudinal pattern of differentially sensitive cells. Dev. Biol. 1987;124:379–389. doi: 10.1016/0012-1606(87)90490-8. [DOI] [PubMed] [Google Scholar]
  • 10.Rossi F, Jankovski A, Sotelo C. Target neuron controls the integrity of afferent axon phenotype: A study on the Purkinje cell-climbing fiber system in cerebellar mutant mice. J. Neurosci. 1995;15:2040–2056. doi: 10.1523/JNEUROSCI.15-03-02040.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Dusart I, Guenet JL, Sotelo C. Purkinje cell death: Differences between developmental cell death and neurodegenerative death in mutant mice. Cerebellum. 2006;5:163–173. doi: 10.1080/14734220600699373. [DOI] [PubMed] [Google Scholar]
  • 12.Porras-García ME, Ruiz R, Pérez-Villegas EM, Armengol JA. Motor learning of mice lacking cerebellar Purkinje cells. Front. Neuroanat. 2013;7:4. doi: 10.3389/fnana.2013.00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Ruiz R, Pérez-Villegas EM, Bachiller S, Rosa JL, Armengol JA. HERC 1 ubiquitin ligase mutation affects neocortical, CA3 hippocampal and spinal cord projection neurons: An ultrastructural study. Front. Neuroanat. 2016;10:42. doi: 10.3389/fnana.2016.00042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Pérez-Villegas EM, et al. Mutation of the HERC 1 ubiquitin ligase impairs associative learning in the lateral amygdala. Mol. Neurobiol. 2018;55:1157–1168. doi: 10.1007/s12035-016-0371-8. [DOI] [PubMed] [Google Scholar]
  • 15.Bachiller S, et al. HERC1 ubiquitin ligase is required for normal axonal myelination in the peripheral nervous system. Mol. Neurobiol. 2018;55:8856–8868. doi: 10.1007/s12035-018-1021-0. [DOI] [PubMed] [Google Scholar]
  • 16.Bachiller S, et al. The HERC1 E3 ubiquitin ligase is essential for normal development and for neurotransmission at the mouse neuromuscular junction. Cell. Mol. Life Sci. 2015;72:2961–2971. doi: 10.1007/s00018-015-1878-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Rosa JL, Barbacid M. A giant protein that stimulates guanine nucleotide exchange on ARF1 and Rab proteins forms a cytosolic ternary complex with clathrin and Hsp70. Oncogene. 1997;15:1–6. doi: 10.1038/sj.onc.1201170. [DOI] [PubMed] [Google Scholar]
  • 18.Rizzoli SO, Betz WJ. Synaptic vesicle pools. Nat. Rev. Neuroci. 2005;6:57–69. doi: 10.1038/nrn1583. [DOI] [PubMed] [Google Scholar]
  • 19.Betz WJ, Bewick GS. Optical analysis of synaptic vesicle recycling at the frog neuromuscular junction. Science. 1992;225:200–203. doi: 10.1126/science.1553547. [DOI] [PubMed] [Google Scholar]
  • 20.Durán E, et al. Synaptotagmin-7 controls the size of the reserve and resting pools of synaptic vesicles in hippocampal neurons. Cell Calcium. 2018;74:53–60. doi: 10.1016/j.ceca.2018.06.004. [DOI] [PubMed] [Google Scholar]
  • 21.Caceres A, Banker G, Steward O, Binder L, Payne M. MAP2 is localized to the dendrites of hippocampal neurons which develop in culture. Brain Res. 1984;315:314–318. doi: 10.1016/0165-3806(84)90167-6. [DOI] [PubMed] [Google Scholar]
  • 22.Südhof TC. Synaptotagmins: Why so many? J Biol Chem. 2002;277:7629–7632. doi: 10.1074/jbc.R100052200. [DOI] [PubMed] [Google Scholar]
  • 23.Heuser JE, Reese TS. Evidence for recycling of synaptic vesicle membrane during transmitter release at the frog neuromuscular junction. J. Cell Biol. 1973;57:315–344. doi: 10.1083/jcb.57.2.315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Jähne S, Rizzoli SO, Helm MS. The structure and function of presynaptic endosomes. Exp Cell Res. 2016;335:172–179. doi: 10.1016/j.exce.2015.04.017. [DOI] [PubMed] [Google Scholar]
  • 25.Milosevic I. Revisiting the role of clathrin-mediated endocytosis in synaptic vesicle recycling. Front. Cell. Neurosci. 2018;12:27. doi: 10.3389/fncel.2018.00027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Baba M, Takeshige K, Baba N, Ohsumi Y. Ultrastructural analysis of the autophagic process in yeast: Detection of autophagosomes and their characterization. J. Cell Biol. 1994;124:903–913. doi: 10.1083/jcb.124.6.903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Utine GE, et al. HERC1 mutations in idiopathic intellectual disability. Eur. J. Med. Genet. 2017;60:279–283. doi: 10.1016/j.ejmg.2017.03.007. [DOI] [PubMed] [Google Scholar]
  • 28.Napoletano F, Baron O, Vandenabeele P, Mollereau B, Fanto M. Intersection between regulated cell death and autophagy. Trends Cell Biol. 2019;29:323–338. doi: 10.1016/j.tcb.2018.12.007. [DOI] [PubMed] [Google Scholar]
  • 29.de Vrij FM, Fischer DF, van Leeuwen FW, Hol EM. Protein quality control in Alzheimer’s disease by the ubiquitin proteasome system. Prog. Neurobiol. 2004;74:249–270. doi: 10.1016/j.pneurobio.2004.10.001. [DOI] [PubMed] [Google Scholar]
  • 30.Upadhya SC, Hegde AN. Ubiquitin-proteasome pathway components as therapeutic targets for CNS maladies. Curr. Pharm. Des. 2005;11:3807–3828. doi: 10.2174/138161205774580651. [DOI] [PubMed] [Google Scholar]
  • 31.Rubinsztein DC. The roles of intracellular protein-degradation pathways in neurodegeneration. Nature. 2006;443:780–786. doi: 10.1038/nature05291. [DOI] [PubMed] [Google Scholar]
  • 32.Hegde AN, Upadhya SC. The ubiquitin-proteasome pathway in health and disease of the nervous system. Trends Neurosci. 2007;30:587–595. doi: 10.1016/j.tins.2007.08.005. [DOI] [PubMed] [Google Scholar]
  • 33.Sulistio YA, Heese K. The ubiquitin-proteasome system and molecular chaperone deregulation in Alzheimer's disease. Mol. Neurobiol. 2016;53:905–931. doi: 10.1007/s12035-014-9063-4. [DOI] [PubMed] [Google Scholar]
  • 34.Menzies FM, et al. Autophagy and neurodegeneration: Pathogenic mechanisms and therapeutic opportunities. Neuron. 2017;93:1015–1034. doi: 10.1016/j.neuron.2017.01.022. [DOI] [PubMed] [Google Scholar]
  • 35.Vijayan V, Verstreken P. Autophagy in the presynaptic compartment in health and disease. J. Cell Biol. 2017;216:1895–1906. doi: 10.1083/jcb.201611113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Wang YC, Lauwers E, Verstreken P. Presynaptic protein homeostasis and neuronal function. Curr. Opin. Genet. Dev. 2017;44:38–46. doi: 10.1016/j.gde.2017.01.015. [DOI] [PubMed] [Google Scholar]
  • 37.Lüningschrör P, Sendtner M. Autophagy in the presynaptic compartment. Curr. Opin. Neurobiol. 2018;51:80–85. doi: 10.1016/j.conb.2018.02.023. [DOI] [PubMed] [Google Scholar]
  • 38.Nikoletopoulou V, Tavernarakis N. Regulation and roles of autophagy at synapses. Trends Cell Biol. 2018;28:646–661. doi: 10.1016/j.tcb.2018.03.006. [DOI] [PubMed] [Google Scholar]
  • 39.Yue Z. Regulation of neuronal autophagy in axon. Autophagy. 2007;3:139–141. doi: 10.4161/auto.3602. [DOI] [PubMed] [Google Scholar]
  • 40.Yue Z, Wang QJ, Komatsu M. Neuronal autophagy: Going the distance to the axon. Autophagy. 2008;4:94–96. doi: 10.4161/auto.5202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Maday S, Holzbaur EL. Autophagosome biogenesis in primary neurons follows an ordered and spatially regulated pathway. Dev. Cell. 2014;30:71–85. doi: 10.1016/j.devcel.2014.06.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.He M, et al. Autophagy induction stabilizes microtubules and promotes axon regeneration after spinal cord injury. Proc. Natl. Acad. Sci. USA. 2016;113:11324–11329. doi: 10.1073/pnas.1611282113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Morgan JR, Comstra HS, Cohen M, Faundez V. Presynaptic membrane retrieval and endosome biology: Defining molecularly heterogeneous synaptic vesicles. Cold Spring Harb. Perspect. Biol. 2013;1:16915. doi: 10.1101/cshperspect.a016915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Soykan T, Maritzen T, Haucke V. Modes and mechanisms of synaptic vesicle recycling. Curr. Opin. Neurobiol. 2016;39:17–23. doi: 10.1016/j.conb.2016.03.005. [DOI] [PubMed] [Google Scholar]
  • 45.Watanabe S, Boucrot E. Fast and ultrafast endocytosis. Curr. Opin. Cell Biol. 2017;47:64–71. doi: 10.1016/j.ceb.2017.02.013. [DOI] [PubMed] [Google Scholar]
  • 46.Kaur G, Lakkaraju A. Early endosome morphology in health and disease. Adv. Exp. Med. Biol. 2018;1074:335–343. doi: 10.1007/978-3-319-75402-4_41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Gauthier-Kemper A, Kahms M, Klingauf J. Restoring synaptic vesicles during compensatory endocytosis. Essays Biochem. 2015;57:121–134. doi: 10.1042/bse0570121. [DOI] [PubMed] [Google Scholar]
  • 48.Kononenko NL, et al. Clathrin/AP-2 mediate synaptic vesicle reformation from endosome-like vacuoles but are not essential for membrane retrieval at central synapses. Neuron. 2014;82:981–988. doi: 10.1016/j.neuron.2014.05.007. [DOI] [PubMed] [Google Scholar]
  • 49.Fernandes AC, et al. Reduced synaptic vesicle protein degradation at lysosomes curbs TBC1D24/sky-induced neurodegeneration. J. Cell Biol. 2014;207:453–462. doi: 10.1083/jcb.201406026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Binotti B, et al. The GTPase Rab26 links synaptic vesicles to the autophagy pathway. Elife. 2015;4:e05597. doi: 10.7554/eLife.05597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.García-Gonzalo FR, Bartrons R, Ventura F, Rosa JL. Requeriment of phosphatidylinositol-4,5-biphosphate for HERC1-mediated guanine nucleotide release from ARF proteins. FEBS Lett. 2005;579:343–348. doi: 10.1016/j.febslet.2004.11.095. [DOI] [PubMed] [Google Scholar]
  • 52.Song W, Zinsmaier KE. Endophilin and synaptojanin hook up to promote synaptic vesicles endocytosis. Neuron. 2003;40:665–667. doi: 10.1016/s0896-6273(03)00726-8. [DOI] [PubMed] [Google Scholar]
  • 53.Vanhauwaert R, et al. The SAC1 domain in synaptojanin is required for autophagosome maturation at presynaptic terminals. EMBO J. 2017;8:e83714. doi: 10.15252/embj.201695773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Ravikumar B, Moreau K, Jahreiss L, Puri C, Rubinsztein DC. Plasma membrane contributes to the formation of pre-autophagosomal structures. Nat. Cell Biol. 2010;12:747–757. doi: 10.1038/ncb2078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Rosa JL, Casaroli-Marano RP, Buckler AJ, Vilaró S, Barbacid M. p619, a giant protein related to the chromosome condensation regulator RCC1, stimulates guanine nucleotide exchange on ARF1 and Rab proteins. EMBO J. 1996;15:4262–4273. [PMC free article] [PubMed] [Google Scholar]
  • 56.Shimobayashi M, Hall MN. Making new contacts: The mTOR network in metabolism and signalling crosstalk. Nat. Rev. Mol. Cell. Biol. 2014;15:155–162. doi: 10.1038/nrm3757. [DOI] [PubMed] [Google Scholar]
  • 57.Hernandez D, et al. Regulation of presynaptic neurotransmission by macroautophagy. Neuron. 2012;74:277–284. doi: 10.1016/j.neuron.2012.02.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Chong-Kopera H, et al. TSC1 stabilizes TSC2 by inhibiting the interaction between TSC2 and the HERC1 ubiquitin ligase. J. Biol. Chem. 2006;281:8313–8316. doi: 10.1074/jbc.C500451200. [DOI] [PubMed] [Google Scholar]
  • 59.Schikorski T, Stevens CF. Morphological correlates of functionally defined synaptic vesicle populations. Nat. Neurosci. 2001;4:391–395. doi: 10.1038/86042. [DOI] [PubMed] [Google Scholar]
  • 60.Casas-Terradellas E, et al. Simultaneous electrophoretic analysis of proteins of very high and low molecular weights using low-percentage acrylamide gel and a gradient SDS-PAG gel. Electrophoresis. 2006;27:3935–3938. doi: 10.1002/elps.200600141. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary information (6.6MB, pdf)

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES